GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)

 TNR6_MACMU              Reviewed;         333 AA.
Q9BDP2;
19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
01-JUN-2001, sequence version 1.
10-FEB-2021, entry version 104.
RecName: Full=Tumor necrosis factor receptor superfamily member 6;
AltName: Full=Apo-1 antigen;
AltName: Full=Apoptosis-mediating surface antigen FAS;
AltName: Full=FASLG receptor;
AltName: CD_antigen=CD95;
Flags: Precursor;
Name=FAS; Synonyms=APT1, TNFRSF6;
Macaca mulatta (Rhesus macaque).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
Cercopithecidae; Cercopithecinae; Macaca.
NCBI_TaxID=9544;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-75; LYS-89; LYS-196 AND
HIS-201.
PubMed=11491535; DOI=10.1007/s002510100322;
Villinger F.J., Bostik P., Mayne A.E., King C.L., Genain C.P., Weiss W.R.,
Ansari A.A.;
"Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-
ligand and co-stimulatory molecules.";
Immunogenetics 53:315-328(2001).
-!- FUNCTION: Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits
caspase-8 to the activated receptor. The resulting death-inducing
signaling complex (DISC) performs caspase-8 proteolytic activation
which initiates the subsequent cascade of caspases (aspartate-specific
cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may
have a role in the induction of peripheral tolerance, in the antigen-
stimulated suicide of mature T-cells, or both (By similarity).
{ECO:0000250}.
-!- SUBUNIT: Binds DAXX. Interacts with HIPK3 (By similarity). Part of a
complex containing HIPK3 and FADD (By similarity). Binds RIPK1 and
FAIM2. Interacts with BABAM2 and FEM1B. Interacts with FADD (By
similarity). Interacts directly (via DED domain) with NOL3 (via CARD
domain); inhibits death-inducing signaling complex (DISC) assembly by
inhibiting the increase in FAS-FADD binding induced by FAS activation
(By similarity). Interacts with CALM (By similarity). In the absence of
stimulation, interacts with BIRC2, DDX3X and GSK3B. The interaction
with BIRC2 and DDX3X is further enhanced upon receptor stimulation and
accompanied by DDX3X and BIRC2 cleavage (By similarity).
{ECO:0000250|UniProtKB:P25445, ECO:0000250|UniProtKB:P25446}.
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P51867};
Single-pass type I membrane protein {ECO:0000250|UniProtKB:P51867}.
Membrane raft {ECO:0000250|UniProtKB:P25445}.
-!- DOMAIN: Contains a death domain involved in the binding of FADD, and
maybe to other cytosolic adapter proteins.
-!- PTM: Palmitoylated. Palmitoylation by ZDHHC7 prevents the lysosomal
degradation of FAS regulating its expression at the plasma membrane.
{ECO:0000250|UniProtKB:P25445}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AF344833; AAK37529.1; -; mRNA.
RefSeq; NP_001028105.1; NM_001032933.2.
SMR; Q9BDP2; -.
STRING; 9544.ENSMMUP00000014651; -.
GeneID; 574332; -.
KEGG; mcc:574332; -.
CTD; 355; -.
eggNOG; ENOG502S0SV; Eukaryota.
InParanoid; Q9BDP2; -.
Proteomes; UP000006718; Unplaced.
GO; GO:0031265; C:CD95 death-inducing signaling complex; IBA:GO_Central.
GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0045121; C:membrane raft; IBA:GO_Central.
GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
GO; GO:0005031; F:tumor necrosis factor-activated receptor activity; IBA:GO_Central.
GO; GO:0006924; P:activation-induced cell death of T cells; IBA:GO_Central.
GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; IBA:GO_Central.
GO; GO:0006955; P:immune response; IEA:InterPro.
GO; GO:0097049; P:motor neuron apoptotic process; IBA:GO_Central.
GO; GO:0097527; P:necroptotic signaling pathway; IBA:GO_Central.
GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
GO; GO:2001269; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway; IBA:GO_Central.
GO; GO:0032872; P:regulation of stress-activated MAPK cascade; IBA:GO_Central.
CDD; cd08316; Death_FAS_TNFRSF6; 1.
CDD; cd10579; TNFRSF6; 1.
InterPro; IPR011029; DEATH-like_dom_sf.
InterPro; IPR000488; Death_domain.
InterPro; IPR008063; Fas_rcpt.
InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
InterPro; IPR033998; TNFRSF6_death.
InterPro; IPR033999; TNFRSF6_N.
PANTHER; PTHR46874; PTHR46874; 1.
Pfam; PF00531; Death; 1.
Pfam; PF00020; TNFR_c6; 2.
PRINTS; PR01680; TNFACTORR6.
SMART; SM00005; DEATH; 1.
SMART; SM00208; TNFR; 2.
SUPFAM; SSF47986; SSF47986; 1.
PROSITE; PS50017; DEATH_DOMAIN; 1.
PROSITE; PS00652; TNFR_NGFR_1; 2.
PROSITE; PS50050; TNFR_NGFR_2; 2.
2: Evidence at transcript level;
Apoptosis; Calmodulin-binding; Cell membrane; Disulfide bond; Glycoprotein;
Lipoprotein; Membrane; Palmitate; Phosphoprotein; Receptor;
Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
SIGNAL 1..25
/evidence="ECO:0000255"
CHAIN 26..333
/note="Tumor necrosis factor receptor superfamily member 6"
/id="PRO_0000034565"
TOPO_DOM 26..173
/note="Extracellular"
/evidence="ECO:0000255"
TRANSMEM 174..194
/note="Helical"
/evidence="ECO:0000255"
TOPO_DOM 195..333
/note="Cytoplasmic"
/evidence="ECO:0000255"
REPEAT 47..83
/note="TNFR-Cys 1"
REPEAT 84..127
/note="TNFR-Cys 2"
REPEAT 128..166
/note="TNFR-Cys 3"
DOMAIN 228..312
/note="Death"
/evidence="ECO:0000255|PROSITE-ProRule:PRU00064"
REGION 211..315
/note="Interaction with HIPK3"
/evidence="ECO:0000250"
REGION 228..252
/note="Interaction with CALM"
/evidence="ECO:0000250|UniProtKB:P25445"
MOD_RES 213
/note="Phosphothreonine"
/evidence="ECO:0000250|UniProtKB:P25446"
MOD_RES 223
/note="Phosphoserine"
/evidence="ECO:0000250|UniProtKB:P25445"
MOD_RES 320
/note="Phosphothreonine"
/evidence="ECO:0000250|UniProtKB:P25446"
LIPID 198
/note="S-palmitoyl cysteine"
/evidence="ECO:0000250|UniProtKB:P25445"
CARBOHYD 118
/note="N-linked (GlcNAc...) asparagine"
/evidence="ECO:0000255"
DISULFID 59..73
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 63..82
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 85..101
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 104..119
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 107..127
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 129..143
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 146..157
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
DISULFID 149..165
/evidence="ECO:0000255|PROSITE-ProRule:PRU00206"
VARIANT 75
/note="V -> A"
/evidence="ECO:0000269|PubMed:11491535"
VARIANT 89
/note="E -> K"
/evidence="ECO:0000269|PubMed:11491535"
VARIANT 196
/note="E -> K"
/evidence="ECO:0000269|PubMed:11491535"
VARIANT 201
/note="R -> H"
/evidence="ECO:0000269|PubMed:11491535"
SEQUENCE 333 AA; 37468 MW; 98C17F766762F287 CRC64;
MLGIWTLLPL VLTSVVRLLS KCVNAQVTDI SSKGFELRKI VTTIETQNLE GLHHEGQFCR
NPCPPGERKA RDCTVNEDEP DCVPCQEGEE YTDKGHFSSK CRRCRLCDEG HGLEVEINCT
RTQNTKCRCK PNFFCNSAVC EHCDPCTKCK HGIIEECTLT SNTKCKEEDS RSDLLWLCLL
LLLLLIPPIV YVVIKEPCRK RRKENQGPHE STTLNPETAI NLSDVDLSKY ITTIAGAMTL
SQVKDFVRKN GVSEAKIDEI KNDNVQDTAE QKVQLLRNWY QLHGKKDACD TLIKGLKTAD
LCTLAEKIHA VILKDITSDT ENSNFGNEVQ NLV


Related products :

Catalog number Product name Quantity
15-288-22767 Tumor necrosis factor receptor superfamily member 6 - FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 0.05 mg
15-288-22766 Tumor necrosis factor receptor superfamily member 6 - FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 0.05 mg
15-288-22766 Tumor necrosis factor receptor superfamily member 6 - FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 0.1 mg
15-288-22767 Tumor necrosis factor receptor superfamily member 6 - FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 0.1 mg
E0030p ELISA kit Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FASLG receptor,Pig,Sus scrofa,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
E0030p ELISA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FASLG receptor,Pig,Sus scrofa,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
U0030p CLIA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FASLG receptor,Pig,Sus scrofa,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
E0030m ELISA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Mouse,Mus musculus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
E0030m ELISA kit Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Mouse,Mus musculus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
E0030b ELISA kit Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,Bos taurus,Bovine,FAS,FASLG receptor,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
E0030b ELISA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,Bos taurus,Bovine,FAS,FASLG receptor,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
E0030r ELISA kit Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Rat,Rattus norvegicus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
E0030r ELISA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Rat,Rattus norvegicus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
U0030b CLIA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,Bos taurus,Bovine,FAS,FASLG receptor,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
U0030m CLIA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Mouse,Mus musculus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
U0030r CLIA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,Apt1,Fas,FASLG receptor,Rat,Rattus norvegicus,Tnfrsf6,Tumor necrosis factor receptor superfamily member 6 96T
E0030h ELISA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FAS1,FASLG receptor,Homo sapiens,Human,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
E0030h ELISA kit Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FAS1,FASLG receptor,Homo sapiens,Human,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
U0030h CLIA Apo-1 antigen,Apoptosis-mediating surface antigen FAS,APT1,FAS,FAS1,FASLG receptor,Homo sapiens,Human,TNFRSF6,Tumor necrosis factor receptor superfamily member 6 96T
20-272-192193 CD95 - Mouse monoclonal [LT95] to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Monoclonal 0.1 mg
20-272-191816 CD95 - Mouse monoclonal [IPO-4] to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Monoclonal 0.05 mg
18-272-197102 CD95 - Rabbit polyclonal to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 1 ml
18-272-197001 CD95 - Rabbit polyclonal to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Polyclonal 0.5 ml
20-272-190031 CD95 - Mouse monoclonal [SA8 ] to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Monoclonal 0.1 mg
20-272-190666 CD95 - Mouse monoclonal [UT - 1] to CD95; FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen; CD95 antigen Monoclonal 0.1 mg
Pathways :
WP2328: Allograft rejection
WP444: Signaling of Hepatocyte Growth Factor Receptor
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP1424: Globo Sphingolipid Metabolism
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP2272: Pathogenic Escherichia coli infection
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP94: Signaling of Hepatocyte Growth Factor Receptor
WP252: Androgen Receptor Signaling Pathway
WP1004: Kit Receptor Signaling Pathway
WP1341: Kit Receptor Signaling Pathway
WP2079: Serotonin Receptor 2 and STAT3 Signaling
WP894: T Cell Receptor Signaling Pathway
WP2140: MaxYvesSuperCombo
WP26: Signal Transduction of S1P Receptor
WP783: Androgen Receptor Signaling Pathway
WP1018: Apoptosis
WP1351: Apoptosis
WP285: B Cell Receptor Signaling Pathway
WP794: B Cell Receptor Signaling Pathway

Related Genes :
[FAS APT1 FAS1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[Fas Apt1 Tnfrsf6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[Fas Apt1 Tnfrsf6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[Faslg Apt1Lg1 Cd95l Fasl Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[FAS APT1 TNFRSF6] Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95)
[CD40 TNFRSF5] Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40)
[CD27 TNFRSF7] CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27)
[CD40LG CD40L TNFSF5 TRAP] CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]
[Tnfrsf21 Dr6] Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358)
[Ceacam1 Bgp Bgp1] Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (Biliary glycoprotein D) (MHVR1) (Murine hepatitis virus receptor) (MHV-R) (CD antigen CD66a)
[Tnfrsf14 hvem] Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)
[TNFRSF14 HVEA HVEM UNQ329/PRO509] Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270)
[Sirpa Bit Myd1 Ptpns1 Shps1 Sirp] Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (mSIRP-alpha1) (p84) (CD antigen CD172a)
[Tnfsf11 Opgl Rankl Trance] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[Cd40lg Cd40l Tnfsf5] CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]
[TNFRSF13B TACI] Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267)
[TNFSF11 OPGL RANKL TRANCE] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[NGFR TNFRSF16] Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271)
[BSG UNQ6505/PRO21383] Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)
[LILRB1 ILT2 LIR1 MIR7] Leukocyte immunoglobulin-like receptor subfamily B member 1 (LIR-1) (Leukocyte immunoglobulin-like receptor 1) (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2) (ILT-2) (Monocyte/macrophage immunoglobulin-like receptor 7) (MIR-7) (CD antigen CD85j)
[TNFRSF21 DR6 UNQ437/PRO868] Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358)
[TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738] Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]
[Sirpa Bit Mfr Ptpns1 Shps1 Sirp] Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (Macrophage membrane protein MFP150) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (CD antigen CD172a)
[FADD MORT1 GIG3] FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity)
[SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP] Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a)

Bibliography :
[11455969] The kiss of death: promises and failures of death receptors and ligands in cancer therapy.